Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 48 | 2024 | 3769 | 4.010 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 22 | 2019 | 541 | 2.680 |
Why?
|
Creatine | 24 | 2023 | 427 | 1.600 |
Why?
|
Inositol | 15 | 2024 | 215 | 1.470 |
Why?
|
Aspartic Acid | 24 | 2024 | 576 | 1.470 |
Why?
|
Simian immunodeficiency virus | 14 | 2019 | 809 | 1.170 |
Why?
|
Choline | 22 | 2023 | 515 | 1.160 |
Why?
|
Macaca mulatta | 26 | 2019 | 2329 | 1.020 |
Why?
|
Gangliosidoses, GM2 | 2 | 2023 | 20 | 0.980 |
Why?
|
Brain | 39 | 2024 | 27121 | 0.930 |
Why?
|
Glutamic Acid | 8 | 2024 | 1176 | 0.910 |
Why?
|
Amyotrophic Lateral Sclerosis | 6 | 2021 | 1469 | 0.820 |
Why?
|
Magnetic Resonance Imaging | 36 | 2024 | 36426 | 0.790 |
Why?
|
Glioblastoma | 5 | 2021 | 3483 | 0.710 |
Why?
|
Spectrum Analysis | 2 | 2021 | 453 | 0.690 |
Why?
|
Spinocerebellar Ataxias | 3 | 2024 | 105 | 0.600 |
Why?
|
Carbon Radioisotopes | 1 | 2018 | 561 | 0.560 |
Why?
|
Brain Neoplasms | 8 | 2021 | 9032 | 0.550 |
Why?
|
Acetamides | 1 | 2018 | 256 | 0.540 |
Why?
|
Echo-Planar Imaging | 1 | 2021 | 663 | 0.540 |
Why?
|
Minocycline | 3 | 2018 | 169 | 0.540 |
Why?
|
Anti-Retroviral Agents | 6 | 2022 | 1784 | 0.540 |
Why?
|
Gyrus Cinguli | 1 | 2022 | 1115 | 0.520 |
Why?
|
Protons | 9 | 2019 | 1116 | 0.520 |
Why?
|
Lymphocyte Depletion | 4 | 2013 | 602 | 0.500 |
Why?
|
Brain Chemistry | 2 | 2016 | 960 | 0.480 |
Why?
|
Brain Diseases | 3 | 2022 | 1546 | 0.460 |
Why?
|
Biopolymers | 1 | 2013 | 184 | 0.410 |
Why?
|
Angiogenesis Inhibitors | 2 | 2021 | 2048 | 0.390 |
Why?
|
Cerebellar Ataxia | 2 | 2023 | 150 | 0.390 |
Why?
|
Positron-Emission Tomography | 5 | 2024 | 6484 | 0.380 |
Why?
|
AIDS Dementia Complex | 5 | 2016 | 153 | 0.360 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2016 | 4580 | 0.360 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2010 | 34 | 0.350 |
Why?
|
Neurons | 7 | 2018 | 9463 | 0.340 |
Why?
|
RNA, Viral | 1 | 2018 | 2846 | 0.330 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2018 | 2199 | 0.330 |
Why?
|
Central Nervous System | 2 | 2016 | 1336 | 0.330 |
Why?
|
Pyridines | 3 | 2024 | 2875 | 0.320 |
Why?
|
Diffusion Tensor Imaging | 2 | 2020 | 2400 | 0.320 |
Why?
|
Neuroprotective Agents | 2 | 2010 | 957 | 0.270 |
Why?
|
Neovascularization, Pathologic | 2 | 2016 | 2645 | 0.270 |
Why?
|
Adrenoleukodystrophy | 1 | 2008 | 143 | 0.270 |
Why?
|
Energy Metabolism | 3 | 2020 | 2882 | 0.260 |
Why?
|
Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2024 | 15 | 0.240 |
Why?
|
Ketones | 2 | 2022 | 184 | 0.230 |
Why?
|
Image Processing, Computer-Assisted | 7 | 2020 | 9001 | 0.230 |
Why?
|
Machado-Joseph Disease | 1 | 2023 | 26 | 0.230 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2022 | 1141 | 0.220 |
Why?
|
Gliosis | 2 | 2020 | 245 | 0.220 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18255 | 0.210 |
Why?
|
Neurodegenerative Diseases | 2 | 2023 | 1088 | 0.210 |
Why?
|
Benzodioxoles | 1 | 2023 | 75 | 0.210 |
Why?
|
Aminophenols | 1 | 2023 | 87 | 0.210 |
Why?
|
Seizures | 1 | 2016 | 2957 | 0.210 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2022 | 74 | 0.200 |
Why?
|
Sandhoff Disease | 1 | 2021 | 14 | 0.190 |
Why?
|
Tay-Sachs Disease | 1 | 2021 | 20 | 0.190 |
Why?
|
Misonidazole | 2 | 2018 | 33 | 0.190 |
Why?
|
Central Nervous System Diseases | 3 | 2015 | 520 | 0.190 |
Why?
|
Humans | 58 | 2024 | 761596 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9280 | 0.180 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 450 | 0.180 |
Why?
|
Quinolones | 1 | 2023 | 378 | 0.170 |
Why?
|
Male | 37 | 2024 | 360846 | 0.170 |
Why?
|
Viral Load | 6 | 2011 | 3332 | 0.160 |
Why?
|
Thalamus | 2 | 2023 | 1047 | 0.150 |
Why?
|
Motor Neurons | 3 | 2021 | 870 | 0.150 |
Why?
|
Epilepsy | 1 | 2013 | 3290 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Post-Concussion Syndrome | 1 | 2020 | 243 | 0.150 |
Why?
|
Middle Aged | 23 | 2024 | 220921 | 0.140 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 256 | 0.140 |
Why?
|
Female | 33 | 2024 | 392705 | 0.140 |
Why?
|
Fibromyalgia | 1 | 2021 | 405 | 0.130 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2011 | 553 | 0.130 |
Why?
|
Glutarates | 1 | 2018 | 243 | 0.130 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 649 | 0.130 |
Why?
|
Glutamine | 2 | 2017 | 577 | 0.130 |
Why?
|
Synaptophysin | 3 | 2011 | 139 | 0.130 |
Why?
|
Parietal Lobe | 1 | 2021 | 852 | 0.130 |
Why?
|
Adult | 21 | 2024 | 221210 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14608 | 0.130 |
Why?
|
Lasers | 1 | 2019 | 952 | 0.120 |
Why?
|
Treatment Failure | 1 | 2021 | 2643 | 0.120 |
Why?
|
Indoles | 1 | 2023 | 1833 | 0.120 |
Why?
|
Biological Factors | 1 | 2016 | 157 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 5 | 2018 | 4062 | 0.120 |
Why?
|
Low Back Pain | 1 | 2023 | 984 | 0.120 |
Why?
|
Integrin alpha4 | 1 | 2014 | 87 | 0.120 |
Why?
|
Metformin | 1 | 2022 | 906 | 0.120 |
Why?
|
Cystic Fibrosis | 1 | 2023 | 1285 | 0.110 |
Why?
|
Vision, Binocular | 1 | 2015 | 226 | 0.110 |
Why?
|
Consensus | 2 | 2021 | 3124 | 0.110 |
Why?
|
Cerebellum | 1 | 2021 | 1501 | 0.110 |
Why?
|
Animals | 27 | 2019 | 168475 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2010 | 1496 | 0.110 |
Why?
|
Microglia | 3 | 2011 | 1362 | 0.110 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2014 | 357 | 0.110 |
Why?
|
Disease Progression | 4 | 2024 | 13510 | 0.110 |
Why?
|
Basal Ganglia | 1 | 2016 | 554 | 0.110 |
Why?
|
Glucose | 2 | 2022 | 4347 | 0.110 |
Why?
|
Brain Mapping | 5 | 2019 | 6635 | 0.110 |
Why?
|
Aged | 16 | 2024 | 169310 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11742 | 0.100 |
Why?
|
Ephrin-B3 | 1 | 2011 | 12 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.100 |
Why?
|
Monocytes | 3 | 2014 | 2570 | 0.100 |
Why?
|
GAP-43 Protein | 1 | 2011 | 152 | 0.100 |
Why?
|
Radiopharmaceuticals | 2 | 2018 | 2650 | 0.090 |
Why?
|
Pyramidal Tracts | 1 | 2013 | 252 | 0.090 |
Why?
|
Monkey Diseases | 1 | 2011 | 71 | 0.090 |
Why?
|
Ataxia | 2 | 2023 | 306 | 0.090 |
Why?
|
Prognosis | 3 | 2018 | 29629 | 0.090 |
Why?
|
Encephalitis, Viral | 1 | 2011 | 58 | 0.090 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1234 | 0.090 |
Why?
|
Cytoprotection | 1 | 2011 | 200 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1393 | 0.090 |
Why?
|
Flow Cytometry | 2 | 2011 | 5870 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3578 | 0.090 |
Why?
|
Dacarbazine | 1 | 2013 | 559 | 0.090 |
Why?
|
Macaca | 1 | 2011 | 410 | 0.080 |
Why?
|
Camptothecin | 1 | 2013 | 591 | 0.080 |
Why?
|
Motor Cortex | 1 | 2017 | 1007 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2016 | 683 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2020 | 5247 | 0.080 |
Why?
|
Algorithms | 4 | 2022 | 14033 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 833 | 0.080 |
Why?
|
Transducers | 1 | 2010 | 244 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3223 | 0.080 |
Why?
|
Periaqueductal Gray | 1 | 2008 | 110 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 2 | 2011 | 1076 | 0.070 |
Why?
|
Visual Cortex | 1 | 2015 | 1108 | 0.070 |
Why?
|
Atrophy | 2 | 2023 | 1633 | 0.070 |
Why?
|
Nerve Net | 1 | 2020 | 2291 | 0.070 |
Why?
|
Young Adult | 7 | 2024 | 59260 | 0.070 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.070 |
Why?
|
Prospective Studies | 5 | 2024 | 54423 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2011 | 6228 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3713 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11076 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2024 | 4762 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15266 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2015 | 1220 | 0.070 |
Why?
|
Image Enhancement | 3 | 2016 | 2884 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2011 | 1134 | 0.060 |
Why?
|
Automation | 1 | 2008 | 586 | 0.060 |
Why?
|
Tissue Extracts | 1 | 2005 | 141 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.060 |
Why?
|
Spinal Cord | 1 | 2013 | 1819 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 440 | 0.060 |
Why?
|
Aging | 2 | 2022 | 8710 | 0.060 |
Why?
|
Quinazolines | 1 | 2011 | 1371 | 0.060 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2007 | 411 | 0.060 |
Why?
|
Neuroimmunomodulation | 1 | 2006 | 182 | 0.060 |
Why?
|
Child | 4 | 2023 | 80158 | 0.060 |
Why?
|
Cohort Studies | 2 | 2021 | 41495 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4369 | 0.050 |
Why?
|
Astrocytes | 1 | 2011 | 1346 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20100 | 0.050 |
Why?
|
Glioma | 1 | 2018 | 3455 | 0.050 |
Why?
|
HIV Infections | 2 | 2022 | 17354 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2024 | 882 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2850 | 0.050 |
Why?
|
Administration, Oral | 1 | 2010 | 4021 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.050 |
Why?
|
Heterozygote | 1 | 2008 | 2787 | 0.050 |
Why?
|
Body Temperature | 1 | 2024 | 781 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2008 | 1836 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12973 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2024 | 26202 | 0.050 |
Why?
|
Survival Rate | 2 | 2013 | 12723 | 0.040 |
Why?
|
Fatty Acids | 1 | 2008 | 1808 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5779 | 0.040 |
Why?
|
Metabolomics | 1 | 2010 | 1659 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2022 | 313 | 0.040 |
Why?
|
Rest | 1 | 2024 | 918 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15843 | 0.040 |
Why?
|
Lipids | 1 | 2010 | 3341 | 0.040 |
Why?
|
Radio Waves | 1 | 2019 | 251 | 0.040 |
Why?
|
Expert Testimony | 1 | 2021 | 364 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12341 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12149 | 0.040 |
Why?
|
Quinolines | 1 | 2023 | 765 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2006 | 1897 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2048 | 0.040 |
Why?
|
Prenatal Diagnosis | 1 | 2024 | 1265 | 0.040 |
Why?
|
Phantoms, Imaging | 2 | 2019 | 2526 | 0.030 |
Why?
|
Anisotropy | 1 | 2020 | 1283 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 783 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9177 | 0.030 |
Why?
|
Hippocampus | 2 | 2024 | 3766 | 0.030 |
Why?
|
Child, Preschool | 2 | 2016 | 42232 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2024 | 1755 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1003 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1667 | 0.030 |
Why?
|
Macrophages | 4 | 2014 | 5767 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2024 | 1161 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 846 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3359 | 0.030 |
Why?
|
Synaptic Transmission | 2 | 2015 | 1173 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13642 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4948 | 0.030 |
Why?
|
Sex Factors | 1 | 2008 | 10554 | 0.030 |
Why?
|
Central Nervous System Infections | 1 | 2014 | 61 | 0.030 |
Why?
|
Cell Count | 2 | 2011 | 1835 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1899 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 778 | 0.030 |
Why?
|
Adolescent | 3 | 2020 | 88326 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2007 | 3049 | 0.030 |
Why?
|
Infant | 1 | 2016 | 36193 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2421 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1301 | 0.030 |
Why?
|
Pyrazoles | 1 | 2023 | 2009 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9610 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 989 | 0.030 |
Why?
|
Virus Replication | 2 | 2011 | 2435 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2022 | 58984 | 0.020 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2018 | 962 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3028 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26129 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39106 | 0.020 |
Why?
|
Spin Labels | 1 | 2013 | 337 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16592 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2013 | 544 | 0.020 |
Why?
|
Acute Disease | 3 | 2007 | 7237 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1440 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2016 | 80647 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2010 | 312 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3060 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5872 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2010 | 445 | 0.020 |
Why?
|
Frontal Lobe | 2 | 2005 | 1420 | 0.020 |
Why?
|
Receptors, IgG | 1 | 2011 | 559 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8633 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 847 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11122 | 0.020 |
Why?
|
Software | 1 | 2021 | 4434 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 945 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6241 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3964 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2008 | 999 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6815 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2009 | 2264 | 0.020 |
Why?
|
Dementia | 1 | 2020 | 2689 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6597 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7581 | 0.020 |
Why?
|
Stroke | 1 | 2007 | 9758 | 0.020 |
Why?
|
Glycine | 1 | 2008 | 663 | 0.010 |
Why?
|
Hydrogen | 1 | 2005 | 172 | 0.010 |
Why?
|
Models, Animal | 1 | 2011 | 2112 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14665 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 1436 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5205 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29890 | 0.010 |
Why?
|
Cognition | 1 | 2020 | 6992 | 0.010 |
Why?
|
Lactic Acid | 1 | 2007 | 1139 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3511 | 0.010 |
Why?
|
Prostate | 1 | 2010 | 1773 | 0.010 |
Why?
|
Viremia | 1 | 2004 | 707 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2011 | 3208 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2011 | 3465 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4352 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2005 | 2358 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22176 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12794 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2007 | 2791 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6312 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10451 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64685 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30053 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9319 | 0.000 |
Why?
|